MKI67 and neoplasm: Whereas tumor volume measurements in Mel006 bearing mice showed that dabrafenib treatment combined with TVB-3664 resulted in a non-significant volume decrease during the course of the study, Ki67 staining of Mel006 tumors revealed that BRAF inhibition combined with FASN inhibition reduces tumor cell proliferation (Fig. 2f).